STRO Message Board Post 10965644 | Sutro Biopharma Inc.
home / stock / stro / stro message board
AviseAnalytics
(investorshangout)
Posted on: Oct/05/2021 12:40:31
Source: investorshangout
https://investorshangout.com/post/view?id=6255482
AviseAnalytics: 4 BIOTECH STOCKS THAT WARRANT YOUR ATTENTION! $STRO $MTEM $SNDX $KRYS Clinical-Stag
News, Short Squeeze, Breakout and More Instantly...
-
SOUTH SAN FRANCISCO, Calif., July 09, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced the appointment of Barbara Leyman, Ph.D., a...
-
- Investigational New Drug application for non-small cell lung cancer trial with luvelta cleared by U.S. Food and Drug Administration; Phase 2 on track to begin dosing in the second half of 2024 - - Patient expansion phase well underway in Phase 2 study of luvelta in combination with be...
-
– Part 2 of REFRαME-O1, the registration-directed study of luvelta for patients with platinum-resistant ovarian cancer (PROC), is open for enrollment – – Planned 50 patients in Dose-Optimization (Part 1) of REFRαME-O1 have been enrolled and are in foll...